Live Breaking News & Updates on Clinical Immunotherapy Program

Stay updated with breaking news from Clinical immunotherapy program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Compugen : 6K-License Agreement with Gilead and entitlement to receive a milestone payment of $10 million from AstraZeneca -December 19, 2023 at 07:24 am EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF. ....

United States , Tel Aviv , Israel General , San Francisco , Foster City , Yvonne Naughton , Jacquie Ross , Meaghan Smith , Flavius Martin , Compugen Ltd Nasdaq , Tel Aviv Stock Exchange , Clinical Immunotherapy Program , Gilead Sciences , Exchange Commission , Compugen Ltd , Corporate Communications , Terms Of The Partnership , Gilead Public Affairs , Commission File Number , Gilead Sciences Inc , Securities Exchange , Company Registration Statement On Form , Rights To Later Stage Development , File Number , Principal Executive Offices , License Agreement ,